- Home
- Publications
- Publication Search
- Publication Details
Title
Novel strategies exploiting interleukin-12 in cancer immunotherapy
Authors
Keywords
-
Journal
PHARMACOLOGY & THERAPEUTICS
Volume 239, Issue -, Pages 108189
Publisher
Elsevier BV
Online
2022-04-14
DOI
10.1016/j.pharmthera.2022.108189
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors
- (2022) Jiemiao Hu et al. Journal for ImmunoTherapy of Cancer
- Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity
- (2022) Yash Agarwal et al. Nature Biomedical Engineering
- A tumor-specific pro-IL-12 activates preexisting cytotoxic T cells to control established tumors
- (2022) Diyuan Xue et al. Science Immunology
- Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma
- (2021) Giulia Agliardi et al. Nature Communications
- Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cells
- (2021) Caleb R. Glassman et al. CELL
- Novel antibodies that selectively block mouse IL‐12 enable the re‐evaluation of the role of IL‐12 in immune protection and pathology
- (2021) Mélanie Gaignage et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Local delivery of mRNA-encoding cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models
- (2021) Christian Hotz et al. Science Translational Medicine
- Oncolytic herpes simplex virus type-1 expressing IL-12 efficiently replicates and kills human colorectal cancer cells
- (2021) Nasrin Haghighi-Najafabadi et al. MICROBIAL PATHOGENESIS
- Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients
- (2020) A. Algazi et al. ANNALS OF ONCOLOGY
- Engineering bionic T cells: signal 1, signal 2, signal 3, reprogramming and the removal of inhibitory mechanisms
- (2020) Iñaki Etxeberria et al. Cellular & Molecular Immunology
- Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma
- (2020) Alain P. Algazi et al. CLINICAL CANCER RESEARCH
- Oncolytic Herpes Simplex Virus Encoding IL12 Controls Triple-Negative Breast Cancer Growth and Metastasis
- (2020) Shanawaz M. Ghouse et al. Frontiers in Oncology
- Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours
- (2020) Aslan Mansurov et al. Nature Biomedical Engineering
- Intratumoral interleukin-12 mRNA therapy promotes TH1 transformation of the tumor microenvironment
- (2020) Susannah L Hewitt et al. CLINICAL CANCER RESEARCH
- PHASE I TRIAL OF ONCOLYTIC ADENOVIRUS-MEDIATED CYTOTOXIC AND INTERLEUKIN-12 GENE THERAPY FOR THE TREATMENT OF METASTATIC PANCREATIC CANCER
- (2020) Kenneth N. Barton et al. Molecular Therapy-Oncolytics
- Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
- (2019) Piotr S. Kowalski et al. MOLECULAR THERAPY
- Development of an Interleukin-12 Fusion Protein That Is Activated by Cleavage with Matrix Metalloproteinase 9
- (2019) Denise Skrombolas et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- IL-27 promotes the expansion of self-renewing CD8+ T cells in persistent viral infection
- (2019) Zhe Huang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy
- (2019) Noor Momin et al. Science Translational Medicine
- Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
- (2019) E. Antonio Chiocca et al. Science Translational Medicine
- 1224PPhase Ib, open-label, dose-escalation study of M9241 (NHS-IL12) plus avelumab in patients (pts) with advanced solid tumours
- (2019) J Strauss et al. ANNALS OF ONCOLOGY
- IL‐35, a double‐edged sword in cancer
- (2019) Zahra Yazdani et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells
- (2019) Iñaki Etxeberria et al. CANCER CELL
- Single injection of IL-12 coacervate as an effective therapy against B16-F10 melanoma in mice
- (2019) Mintai P. Hwang et al. JOURNAL OF CONTROLLED RELEASE
- Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses
- (2019) Samantha K. Greaney et al. Cancer Immunology Research
- Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System® (RTS®) gene switch as gene therapy for the treatment of glioma
- (2018) John A. Barrett et al. CANCER GENE THERAPY
- Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy
- (2018) Jacob M. Ricca et al. MOLECULAR THERAPY
- An RNA toolbox for cancer immunotherapy
- (2018) Fernando Pastor et al. NATURE REVIEWS DRUG DISCOVERY
- A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors
- (2018) Valerio Leoni et al. PLoS Pathogens
- Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma
- (2018) Ian Lai et al. Journal for ImmunoTherapy of Cancer
- Interleukin-35 Limits Anti-Tumor Immunity
- (2016) Meghan E. Turnis et al. IMMUNITY
- Making the Most of Cancer Surgery with Neoadjuvant Immunotherapy
- (2016) I. Melero et al. Cancer Discovery
- Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma
- (2016) Daxa M. Patel et al. Human Gene Therapy Clinical Development
- Interleukin-22: Immunobiology and Pathology
- (2015) Jarrod A. Dudakov et al. Annual Review of Immunology
- Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
- (2015) L. Zhang et al. CLINICAL CANCER RESEARCH
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Virotherapy with a Semliki Forest Virus–Based Vector Encoding IL12 Synergizes with PD-1/PD-L1 Blockade
- (2015) José I. Quetglas et al. Cancer Immunology Research
- The immunocytokine NHS-IL12 as a potential cancer therapeutic
- (2015) Jonathan Fallon et al. Oncotarget
- A requirement of dendritic cell-derived interleukin-27 for the tumor infiltration of regulatory T cells
- (2014) Siyuan Xia et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Tumor-Derived IL-35 Promotes Tumor Growth by Enhancing Myeloid Cell Accumulation and Angiogenesis
- (2013) Z. Wang et al. JOURNAL OF IMMUNOLOGY
- Critical Role of Dendritic Cell-Derived IL-27 in Antitumor Immunity through Regulating the Recruitment and Activation of NK and NKT Cells
- (2013) J. Wei et al. JOURNAL OF IMMUNOLOGY
- Immunotherapeutic Synergy Between Anti-CD137 mAb and Intratumoral Administration of a Cytopathic Semliki Forest Virus Encoding IL-12
- (2012) José I Quetglas et al. MOLECULAR THERAPY
- The composition and signaling of the IL-35 receptor are unconventional
- (2012) Lauren W Collison et al. NATURE IMMUNOLOGY
- A Phase 1 Study of AS1409, a Novel Antibody-Cytokine Fusion Protein, in Patients with Malignant Melanoma or Renal Cell Carcinoma
- (2011) S. M. Rudman et al. CLINICAL CANCER RESEARCH
- Improving Adoptive T Cell Therapy by Targeting and Controlling IL-12 Expression to the Tumor Environment
- (2011) Ling Zhang et al. MOLECULAR THERAPY
- Development of a Liver-specific Tet-On Inducible System for AAV Vectors and Its Application in the Treatment of Liver Cancer
- (2011) Lucia Vanrell et al. MOLECULAR THERAPY
- A human memory T cell subset with stem cell–like properties
- (2011) Luca Gattinoni et al. NATURE MEDICINE
- Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
- (2010) S. P. Kerkar et al. CANCER RESEARCH
- HSV as a vector in vaccine development and gene therapy
- (2010) Peggy Marconi et al. Human vaccines & immunotherapeutics
- Semliki Forest virus-mediated gene therapy of the RG2 rat glioma
- (2010) F. P. Roche et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- TGF-β is necessary for induction of IL-23R and Th17 differentiation by IL-6 and IL-23
- (2009) Noriko Morishima et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effect of Adeno-Associated Virus Serotype and Genomic Structure on Liver Transduction and Biodistribution in Mice of Both Genders
- (2009) Astrid Pañeda et al. HUMAN GENE THERAPY
- Semliki Forest Virus Expressing Interleukin-12 Induces Antiviral and Antitumoral Responses in Woodchucks with Chronic Viral Hepatitis and Hepatocellular Carcinoma
- (2009) J. R. Rodriguez-Madoz et al. JOURNAL OF VIROLOGY
- Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma
- (2008) Adil I. Daud et al. JOURNAL OF CLINICAL ONCOLOGY
- A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses
- (2008) Elisabetta Volpe et al. NATURE IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More